Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy

Fig. 3

Kaplan-Meier survival curves showing overall survival (a), local progression free survival (b), and distant-metastasis free survival (c) in patients with lacrimal gland carcinoma according to T category as determined using the eighth edition of the American Joint Committee on Cancer staging system. * Log-rank test. (a) The 2-year OS rates were 100 and 37.5% in T1–2 and T3–4 groups (p = 0.013), with (b) the 2-year DMFS rates were 100 and 37.5% (p = 0.002), and (c) the 2-year LPFS rates of 100 and 50%, respectively (p = 0.006)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us